Market Cap 4.76B
Revenue (ttm) 2.70B
Net Income (ttm) -128.04M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 236.10
Profit Margin -4.74%
Debt to Equity Ratio 1.99
Volume 1,965,600
Avg Vol 2,629,216
Day's Range N/A - N/A
Shares Out 200.09M
Stochastic %K 98%
Beta 1.16
Analysts Strong Sell
Price Target $24.17

Company Profile

Alignment Healthcare, Inc. operates a consumer-centric healthcare platform for seniors in the United States. It delivers customized healthcare experience to meet the needs of seniors through its Medicare Advantage plans. The company was founded in 2013 and is based in Orange, California.

Industry: Healthcare Plans
Sector: Healthcare
Phone: 844 310 2247
Address:
1100 West Town and Country Road, Suite 1600, Orange, United States
RunnerSignals
RunnerSignals Jan. 23 at 4:35 AM
Hot Technical Moves Today $MRNA $ENPH $ALHC $RIG $WDC showing big momentum and trend shifts https://stocksrunner.com/news/2026-01-22-daily-market-pulse
0 · Reply
Cash_Only_Account
Cash_Only_Account Jan. 15 at 6:38 PM
$CLOV https://finance.yahoo.com/news/alignment-healthcare-details-care-management-202553487.html Wow, look at $ALHC moving to fresh highs here! Amazing to see that their denial rate is less than 2%!! These companies will be the next big winners in Healthcare.
0 · Reply
MrPumpkin123
MrPumpkin123 Jan. 15 at 5:29 PM
0 · Reply
StraightFromThe408
StraightFromThe408 Jan. 14 at 8:32 PM
$CLOV $ALHC 👌 https://x.com/lancepellerin/status/2011509477455904976?s=46
0 · Reply
tartanblaster
tartanblaster Jan. 14 at 7:57 PM
$CLOV interesting Our closest comparator (who also saw great AEP results) $ALHC is also running today Seems to be from UBS analyst price target upgrade. UBS cover clover as well - wouldn't be surprised if we got an upgraded price target as well after tomorrow's JPM conference appearance
0 · Reply
Valuation_Finance
Valuation_Finance Jan. 13 at 6:42 PM
$UNH WSJ came out with a very poor article on UNH and $ALHC. It says health care insurers will do better in 2026 while hospitals like $HCA and $THC that tripled and quintupled in the last 5 years will not do well. In fact, their fortunes will switch per WSJ. If you read the article, though, there are very few favorable developments for insurers. There is a somewhat higher government payment rate (5%) for Medicare Advantage under Trump vs. previously under Biden. But that's about it. You're left scratching your head: is that enough for the fortunes of managed care organizations to abruptly change and outperform hospitals? This is why you should never trust journos with liberal arts backgrounds to analyze moving parts. They're jounos, not analysts. Journos try to weave a narrative but they cannot comprehend market data nor financial statements. Things are only somewhat looking up for UNH and ALHC but they're certainly not gonna triple or quadruple from here. https://www.wsj.com/health/healthcare/why-healthcares-stock-market-winners-and-losers-could-soon-trade-places-d30638e6
0 · Reply
tartanblaster
tartanblaster Jan. 12 at 4:57 PM
$CLOV $ALHC Has announced their AEP results - 31% growth tint bit under their 35% growth last year. Expect all the other MA insurers to announce their AEP results this week, including clover. (Though the official CMS data won't be out till Feb)
1 · Reply
tartanblaster
tartanblaster Jan. 9 at 2:34 PM
$CLOV just a reminder that we are currently well below fair value just on standard valuation metrics/comparators for the core MA business. Currently our EV/Rev multiple is just 0.55, we've not really been that low since mid 2024. Our valuation is well below our closest comparator in $ALHC which has a EV/Rev multiple of 1.07 basically double ours. Such a low multiple for a business growing rev at 50% a year is mad. Significant headroom for share price increase just to get us back to our more typical valuation multiple around 0.8-0.9 As I've said before, if below 3 I buy!
1 · Reply
Theironsheikh
Theironsheikh Dec. 31 at 5:30 PM
$CLOV $ALHC absolutely thrashed us this year Clov = garbage
1 · Reply
ParadigmPulse
ParadigmPulse Dec. 25 at 5:35 PM
$ALHC This ticker is entering a stage where execution quality will overshadow headline narratives. Reliability of results matters more than short bursts of momentum. A series of confirmed wins might reduce the required risk premium. The next phase will be defined less by vision and more by delivery.
0 · Reply
Latest News on ALHC
Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers

Sep 2, 2025, 2:00 PM EDT - 5 months ago

Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers

CI


Alignment Healthcare, Inc. (ALHC) Q4 2024 Earnings Call Transcript

Feb 28, 2025, 5:32 PM EST - 11 months ago

Alignment Healthcare, Inc. (ALHC) Q4 2024 Earnings Call Transcript


Alignment Healthcare Reports Third Quarter 2024 Results

Oct 29, 2024, 4:01 PM EDT - 1 year ago

Alignment Healthcare Reports Third Quarter 2024 Results


RunnerSignals
RunnerSignals Jan. 23 at 4:35 AM
Hot Technical Moves Today $MRNA $ENPH $ALHC $RIG $WDC showing big momentum and trend shifts https://stocksrunner.com/news/2026-01-22-daily-market-pulse
0 · Reply
Cash_Only_Account
Cash_Only_Account Jan. 15 at 6:38 PM
$CLOV https://finance.yahoo.com/news/alignment-healthcare-details-care-management-202553487.html Wow, look at $ALHC moving to fresh highs here! Amazing to see that their denial rate is less than 2%!! These companies will be the next big winners in Healthcare.
0 · Reply
MrPumpkin123
MrPumpkin123 Jan. 15 at 5:29 PM
0 · Reply
StraightFromThe408
StraightFromThe408 Jan. 14 at 8:32 PM
$CLOV $ALHC 👌 https://x.com/lancepellerin/status/2011509477455904976?s=46
0 · Reply
tartanblaster
tartanblaster Jan. 14 at 7:57 PM
$CLOV interesting Our closest comparator (who also saw great AEP results) $ALHC is also running today Seems to be from UBS analyst price target upgrade. UBS cover clover as well - wouldn't be surprised if we got an upgraded price target as well after tomorrow's JPM conference appearance
0 · Reply
Valuation_Finance
Valuation_Finance Jan. 13 at 6:42 PM
$UNH WSJ came out with a very poor article on UNH and $ALHC. It says health care insurers will do better in 2026 while hospitals like $HCA and $THC that tripled and quintupled in the last 5 years will not do well. In fact, their fortunes will switch per WSJ. If you read the article, though, there are very few favorable developments for insurers. There is a somewhat higher government payment rate (5%) for Medicare Advantage under Trump vs. previously under Biden. But that's about it. You're left scratching your head: is that enough for the fortunes of managed care organizations to abruptly change and outperform hospitals? This is why you should never trust journos with liberal arts backgrounds to analyze moving parts. They're jounos, not analysts. Journos try to weave a narrative but they cannot comprehend market data nor financial statements. Things are only somewhat looking up for UNH and ALHC but they're certainly not gonna triple or quadruple from here. https://www.wsj.com/health/healthcare/why-healthcares-stock-market-winners-and-losers-could-soon-trade-places-d30638e6
0 · Reply
tartanblaster
tartanblaster Jan. 12 at 4:57 PM
$CLOV $ALHC Has announced their AEP results - 31% growth tint bit under their 35% growth last year. Expect all the other MA insurers to announce their AEP results this week, including clover. (Though the official CMS data won't be out till Feb)
1 · Reply
tartanblaster
tartanblaster Jan. 9 at 2:34 PM
$CLOV just a reminder that we are currently well below fair value just on standard valuation metrics/comparators for the core MA business. Currently our EV/Rev multiple is just 0.55, we've not really been that low since mid 2024. Our valuation is well below our closest comparator in $ALHC which has a EV/Rev multiple of 1.07 basically double ours. Such a low multiple for a business growing rev at 50% a year is mad. Significant headroom for share price increase just to get us back to our more typical valuation multiple around 0.8-0.9 As I've said before, if below 3 I buy!
1 · Reply
Theironsheikh
Theironsheikh Dec. 31 at 5:30 PM
$CLOV $ALHC absolutely thrashed us this year Clov = garbage
1 · Reply
ParadigmPulse
ParadigmPulse Dec. 25 at 5:35 PM
$ALHC This ticker is entering a stage where execution quality will overshadow headline narratives. Reliability of results matters more than short bursts of momentum. A series of confirmed wins might reduce the required risk premium. The next phase will be defined less by vision and more by delivery.
0 · Reply
JarvisFlow
JarvisFlow Dec. 17 at 7:18 PM
JP Morgan has updated their rating for Alignment Healthcare ( $ALHC ) to Overweight with a price target of 23.
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 10 at 7:13 PM
$ALHC Current Stock Price: $19.11 Contracts to trade: $20 ALHC Dec 19 2025 Call Entry: $0.15 Exit: $0.21 ROI: 43% Hold ~24 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Theironsheikh
Theironsheikh Nov. 25 at 10:15 PM
$CLOV $ALHC up 65% YTD $OSCR up 24% YTD This piece of shit down 23% YTD And people think Toy is a good ceo Motherfucker
4 · Reply
JarvisFlow
JarvisFlow Nov. 24 at 2:56 PM
JP Morgan has updated their rating for Alignment Healthcare ( $ALHC ) to Overweight with a price target of 20.
0 · Reply
tartanblaster
tartanblaster Nov. 21 at 9:50 AM
$CLOV before everyone panics Worth highlighting how good value current metrics puts us P/S - 0.61, 34% lower than our closest comparator $ALHC Value is even more stark when you consider enterprise value (the better metric especially since we have zero debt and reasonable cash reserves) EV/S - 0.45, 45% lower than Alignment Basically 80% upside just to equalise valuation metrics with our peers
1 · Reply
Rorx
Rorx Nov. 15 at 4:39 AM
$ALHC 18 to 21 before it crashes down to around 13 if not lower
0 · Reply
JarvisFlow
JarvisFlow Nov. 5 at 7:29 PM
JP Morgan has adjusted their stance on Alignment Healthcare ( $ALHC ), setting the rating to Neutral with a target price of 17 → 18.
0 · Reply
IN0V8
IN0V8 Nov. 3 at 2:48 PM
$ALHC Barclays raises target price to $18 from $13
0 · Reply
JarvisFlow
JarvisFlow Nov. 3 at 2:20 PM
Barclays has updated their rating for Alignment Healthcare ( $ALHC ) to Equal-Weight with a price target of 18.
0 · Reply
IN0V8
IN0V8 Oct. 31 at 6:53 PM
$ALHC Buy Leerink Partners raises PT to $23 from $20 Stephens raises target price to $24 from $20 UBS raises target price to $18 from $17
0 · Reply
tartanblaster
tartanblaster Oct. 31 at 1:34 PM
$CLOV $ALHC Doing well after very strong earnings yesterday Should give us some confidence that medical cost inflation has levelled us and hopefully see us reporting similarly storing earnings
2 · Reply
AStrokeOfLuck
AStrokeOfLuck Oct. 30 at 9:31 PM
0 · Reply